Recruiting IgA Nephropathy Studies in Los Angeles
About IgA Nephropathy Clinical Trials in Los Angeles
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 3 iga nephropathy clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 821 participants. Research is being sponsored by Biogen, Takeda, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Los Angeles — FAQ
Are there iga nephropathy clinical trials in Los Angeles?
Yes, there are 3 iga nephropathy clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated October 15, 2026 from ClinicalTrials.gov